Related references
Note: Only part of the references are listed.High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
W-F Cheng et al.
BRITISH JOURNAL OF CANCER (2009)
Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways
Po-Ni Hsiao et al.
TOXICOLOGY (2009)
The essential role for c-Ski in mediating TGF-beta 1-induced bi-directional effects on skin fibroblast proliferation through a feedback loop
Xia Liu et al.
BIOCHEMICAL JOURNAL (2008)
Mesothelin promotes anchorage-independent growth and prevents anoikis via extracellular signal-regulated kinase signaling pathway in human breast cancer cells
Norihisa Uehara et al.
MOLECULAR CANCER RESEARCH (2008)
Generation and characterization of an ascitogenic mesothelin-expressing tumor model
Wen-Fang Cheng et al.
CANCER (2007)
Biomarkers in diagnosis of pancreatic carcinoma in fine-needle aspirates - A translational research application
Nirag Jhala et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Mesothelin variant 1 is released from tumor cells as a diagnostic marker
Ingegerd Hellstrom et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma
GH Eltabbakh et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling
K Kato et al.
BIOCHEMICAL JOURNAL (2006)
Soluble mesothelin related protein in mesothelioma
Jenette Creaney et al.
JOURNAL OF THORACIC ONCOLOGY (2006)
Forced expression of ΔN-TCF-1B in colon cancer derived cell lines is accompanied by the induction of CEACAM5/6 and mesothelin
B Liebig et al.
CANCER LETTERS (2005)
A standard curve based method for relative real time PCR data processing
A Larionov et al.
BMC BIOINFORMATICS (2005)
Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK
Y Dai et al.
BLOOD (2005)
Mesothelin-mediated targeting of adenoviral vectors for ovarian cancer gene therapy
M Breidenbach et al.
GENE THERAPY (2005)
Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays
SL Swierczynski et al.
HUMAN PATHOLOGY (2004)
Mesothelin: A new target for immunotherapy
R Hassan et al.
CLINICAL CANCER RESEARCH (2004)
Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions
V Givant-Horwitz et al.
GYNECOLOGIC ONCOLOGY (2003)
Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas
HF Frierson et al.
HUMAN PATHOLOGY (2003)
Gene expression patterns in ovarian carcinomas
ME Schaner et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel
Y Kimura et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Molecular signals in anti-apoptotic survival pathways
DM O'Gorman et al.
LEUKEMIA (2001)
Time trends in ovarian cancer mortality in Europe (1955-1993):: Effect of age, birth cohort and period of death
P González-Diego et al.
EUROPEAN JOURNAL OF CANCER (2000)
Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma
R Hassan et al.
JOURNAL OF IMMUNOTHERAPY (2000)
Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway
T Akimoto et al.
KIDNEY INTERNATIONAL (2000)
Mesothelin is not required for normal mouse development or reproduction
TK Bera et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
The epidemiology of ovarian cancer: A population-based study in Olmsted County, Minnesota, 1935-1991
CM Beard et al.
ANNALS OF EPIDEMIOLOGY (2000)
Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
K Yamamoto et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Share Paper
